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ABSTRACT
Objective: To investigate the effects of pectic polysaccharides extracted from Rauwolfia
verticillata (Lour.) Baill.var.hainanensis Tsiang on an experimental murine colitis model.
Methods: Experimental colitis was induced by dextran sulfate sodium (OSS), and mice were
divided into 4 groups: control, OSS alone, OSS plus SASP, OSS plus pectic polysaccharides. The
disease activity index (OAI) and histological score were observed. The tumor necrosis factor
(fNF)- a and interleukin (IL)-17 levels were measured by enzyme-linked immunosorbent assay.
I Ie Band NF- Ie B p65 expression were assessed by western blot analysis. Myeloperoxidase
(MPO) activity was determined by using MPO assay kit. Results: Administration of pectic
polysaccharides significantly reduced the severity of OSS-induced colitis as assessed by OAIand
histological score, and resulted in down regulation of MPO activity and NF- Ie B p65 expression
and subsequent degradation of I Ie B protein, strikingly reduced the production of TNF- a and
IL-17. Conclusions: Pectic polysaccharides extracted from Rauvoljia verticillata (Lour.Baill.var.
hainanensis Tsiang exerts beneficial effects in experimental colitis and may therefore provide a
useful therapeutic approach for the treatment of DC.
1. Introduction
Ulcerative colitis (UC) is one of the idiopathic forms of
inflammatory bowel disease (IBD). It is a chronic, relapsing
inflammatory disease of the colon, characterized by ulcers in
the colon and rectum. The etiology is still largely unknown.
Environmental and genetic factors in combination with the
microbial flora or specific microorganisms trigger an event,
leading to the activation of an intestinal immune responseltl.
Immune and non-immune cells create a cross talk via
the secretion of soluble mediators and expression of cell
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adhesion molecules, resulting in further cell activation[I,2].
Mediators such as cytokines and chemokines play a role
in cell recruitment and polarization, intercellular signal
amplification or activation and differentiation. Considering
these aspects, medical management of inflammatory bowel
disease has changed considerably over the past decadelsl,
Although much progress has been made in the
management of the disease, definitive causal therapies
for human UC until now are not available. In fact,
5-aminosalicyclic acid and its derivatives are still the drugs
of choice for current medical treatment; corticosteroids,
azathioprine, mercaptopurines and cyclosporine are used
in more severe forms of the disease. However, the therapies
not only show limited benefits but also have serious
side effectsl-l. Plant-sourced formulations purportedly
possess anti-inflammatory and radical scavenging
properties. Despite the lack of sufficient information on
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the safety of herbal products, their use as alternative and/or
complementary medicine is globally popular.
Rauwolfia verticillata (Lour.) Baill.var.hainanensis Tsiang
is an erect evergreen shrub growing wild in the islands of
Hainan. The dried root of Rauwoljia verticillata (Lour.) Baill.
var. hainanensis Tsiang, according to the Pharmacopeia of
the People's Republic of China (2010 ed), is a traditional
Chinese herbal medicine. It has been earlier shown to
possess an anti-inflammatory effect. In China, Rauwolfia
verticillata (Lour.) Baill. var. hainanensis Tsiang has been
extensively used for more than 1000 years in the treatment
for lowering blood pressure, treating arrhythmia and tumors.
However, rauwolfia is rarely used to cure UC. Several
researches found the pectin obtained from Rauvolfia
serpentina 1. could inhibit colitis in mice[5J. However, no
systematic studies on its anti-inflammatory activity and
mechanisms have been reported.
It is widely accepted that activation of the nuclear factor-
IC B (NF- IC B) signaling pathway and overexpression of
associated cytokines such as tumor necrosis factor- a
(TNF- a ), interleukin-6 (IL-6), IL-lO, and interferon- y
(IFN- Y ) play key roles in the development of UC[6,7J. NF-
IC B regulates the expression of multiple pro-inflammation
genes and is thus a key player in maintaining immune
system homeostasis. Thus, inhibition of NF- IC B and its
associated molecules may be a novel therapeutic tool [8].
An increasing number of studies have focused upon the
role of Th17 cells in the pathogenesis of UC. Th17 cells
develop from naive T lymphocytes through distinct pathways
from classical Th1 and Th2 cells. Th17 cells secrete IL-
17, which promotes the recruitment of inflammatory cells
into the intestinal mucosa via its ability to enhance the
synthesis of chemoattractants and adhesion molecules on
epithelial, endothelial and mesenchymal cells. It has been
generally accepted that Th-17 probably playa key role in the
occurrence and development of UC[9,lO].
Therefore, we hypothesized pectic polysaccharides from
Rauvolfia verticillata (Lour.jllaill.var.hainanensis Tsiang
could exert its anti-inflammatory effect on UC by inhibiting
the activation of NF- IC B signaling pathway. In this study, we
extracted pectic polysaccharides from Rauvoljia verticillata
(Lour.) Baill. var. hainanensis Tsiang and elucidated the
effects of anti-inflammatory in a murine model of dextran
sulfate sodium (DSS)-induced colitis, which resembles
human UC, in order to provide experimental evidence that
pectic polysaccharides serves as a possible treatment for
patients with uc.
2. Material and methods
2.1. Pectic polysaccharide extracted from Rauwolfia
verticillata (Lour.) Baill. var. hainanensis Tsiang
Rauwolfia verticillata (Lour.) Baill. var. hainanensis
Tsiang was obtained from the Jianfengling National Forest
Park of Ledong Ii autonomous county, Hainan province,
China. The extract method of pectic polysaccharide was in
accord with Popov et al[5J. Briefly, the rootstock (5 g) dried
at 40·C was treated with diluted net (up to pH 4.4 ) at 50 ·C
for 3 h and the material obtained was extracted with 0.7%
aqueous ammonium oxalate. A polysaccharide fraction
was precipitated with four volumes of 96% ethanol. After
centrifugation at 8000 g for 10 min, precipitate was collected
and dried at 40 ·C. Subsequently, the precipitate was
dissolved in distilled water and stored at -20 ·C.
2.2. Animals
A total of 40 female BALB/c mice (6-8 weeks old, 17-22
g) were purchased from the Huaxi Medical Animal Center
of Sichuang University (Sichuang, China). All animals were
acclimated under standard conditions and maintained in
a 12-h lightl12-h dark cycle at a temperature of 23 ·C±
1 ·C with 55%±5% humidity. The animals were maintained
with free access to a standard diet and tap water. All
experimental procedures were approved by the local Animal
Care and Use Committee, and were conducted following the
guidelines of the animal care policy.
2.3. Drugs and reagents
DSS was purchased from Beijing Bitab Biotechnology Co.
Ltd. (Beijing, China). Salicylazosulfa-pyridine (SASP, used as
a positive control drug) was purchased from
Fuda Pharmaceutical Co. Ltd (China). The mice TNF- a
and IL-17 enzyme-linked immunosorbent assay (ELISA) Kit,
a product of Rand D Systems (United States), was obtained
from Shanghai Chuanxiang Biotechnology Co. Ltd. (Shanghai,
China). The antibodies used in this study were anti-NF- IC
B p65 (ab16502, Abcam), anti-inhibitor ofNF- IC B (I IC B) a
(ab32518, Abeam), Goat anti-rabbit IgGwere purchased from
Boster Biotechnology (Wuhan, Hubei province, China).
2.4. Induction ofcolitis
BALB/c mice were randomly assigned to the following
groups (n=lO per group): control, DSS alone (DSS), DSS
plus SASP (100 mg/kg), DSS plus pectic polysaccharides
(200 p.L). Colitis was induced in BALB/c mice by adding
DSS (molecular weight: 36-50 kDa; MP Biomedicals) to
drinking water at a level of 4% for 7 days. Control animals
were given water only. After 7 d, DSS was then removed
from the drinking water and the animals received 200 p.L of
normal saline (control group and UC group) or SASP (100 mg!
kg, UC plus SASP group) or 200 p. of pectic polysaccharides
(UC plus pectic polysaccharides group) orally each day. All
of the mice were sacrificed by cervical dislocation after 14
days.
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2.5. Evaluation ofdisease activity index
The mice were checked daily for colitis based on body
weight monitoring, gross rectal bleeding, and stool
consistency. The disease activity index (DAI) was assessed
in accordance with the method described by Murano et al[ll].
The DAI was assessed by an investigator who was blind to
the experimental groups.
2.6. Sample collection and histopathological examination
Mice were then sacrificed, and the colon and rectum were
dissociated. After removal of the entire colon and rectum,
the total length was measured, and the colon was then
opened longitudinally, gently washed with ice-cold saline
and blotted dry with filter paper. The colon tissue was
then weighed and cut into several segments. A l-cm colon
segment 2 em from the anus was fully expanded, affixed
to filter paper, and then fixed in 10% neutral formalin.
The tissues were then embedded in paraffin, stained with
hematoxylin and eosin, and assessed under light microscopy.
Colonic damage was scored as described previously. The
remaining colon tissue was stored at -80·C for biochemical
measurements, Western blot analysis and EUSA analysis.
2.7. Determination of/L-17 and TNF- a level
The murine colon tissues were used for cytokines EUSA
analysis. In addition, the murine colon homogenates were
obtained by handwork, and centrifuged at 3 000 rpm, 10
min. The amounts of cytokines in the supernatants for TNF-
a and IL-17 were determined by EUSA according to the
manufacturer's instructions.
2.8. Western blot analysis
Nuclear and cytoplasmic extracts were prepared using a
nuclear and cytoplasmic protein extraction kit (Beyotime,
China). Briefly, colon tissues (approximately 80 mg) were
homogenized in cytoplasmic extraction buffer. Tissue
homogenates were rapidly lysed by vortexing. The
homogenate was centrifuged at 12 000 g for 10 min at 4 ·C
and proteins were collected from the supernatant. The
pellets were re-suspended in 50 p.L of nuclear protein
extraction buffer, lysed by ultrasound in an ice water bath,
and then centrifuged to yield the nuclear fraction. Protein
concentration was measured with a BCA protein assay kit.
Protein samples (50-80 p.g) were separated using 8%-12%
SDS-PAGE gels and transferred onto PVDF membranes.
The membranes were blocked with 5% skim milk in Tris-
buffered saline with Tween 20 for 2 h at room temperature
and then incubated with primary antibodies to anti-NF-
l( B p65 and anti-I I( B a, at a 1:1 000-1:10 000 dilution
overnight at 4 ·C. Then, the membrane was washed 3
times for 10 min each and incubated with a horseradish
peroxidase- conjugated anti-rabbit IgG antibody. Protein
bands were detected using enhanced chemiluminescence
detection kit (Beyotime Institute of Biotechnology) and
visualized by exposure to photographic film. Finally, the
densitometry values of each protein analyte normalized to
GADPH were compared.
2.9. Myeloperoxidase activity
Myeloperoxidase (MPO) activity, an index of leukocyte
recruitment, was measured with a myeloperoxidase assay
kit according to the manufacturer's instructions (CytoStore,
Alberta, Canada).
2.10. Statistical analysis
Statistical analyses were performed using SPSS software
11.5 for Windows. All results are expressed as mean±SD.
Quantitative data were tested for homogeneity of variance. If
the variance was homogeneous, one-way ANOVA followed
by the Bonferroni post hoc test was used. Comparisons
between groups of nonparametric data were made using the
Kruskal-Wallis test followed by the Mann-Whitney U test. P
<0.05 was considered significant
3. Results
3.1. Effects ofpectic polysaccharides on colonic mucosal
damage in DSS-induced colitis
After induction of colitis with DSS, the colonic mucosa
showed congestion, erosion, and hemorrhagic ulcerations.
DAI score were monitored each day. Mice given 4% DSS in
their drinking water for 7 d developed symptoms of colitis.
Compared with control mice, the DAIvalue was significantly
greater from day 9 to 14 in mice treated with DSS (p<0.05,
Table 1).Compared to the DC group, the colitis symptoms
were relieved from day 12 to 14 in mice of the DCplus pectic
polysaccharides group and DCplus SASP group
Treatment of mice with pectic polysaccharides and SASP
significantly meliorated experimental colitis as assessed
by DAI and histological injury scores. As shown in Table 1
and Figure 2. Compared with normal control group, the DAI
scores were increased markedly in mice with DSS-induced
colitis (p<0.05, Table 1). There are no statistically significant
between the two drug treatment groups.
After induction of colitis with DSS, Histological findings
demonstrated marked epithelial destruction, inflammatory
infiltration, crypt distortion, and submucosal edema (Figure
1). The control group given normal saline showed no
histological alterations. Similarly, mice given SASP exhibited
virtually the same normal histology with no inflammatory
cell infiltration, oedema or crypt abscesses. Severe
submucosal oedema, erosion, ulceration, inflammatory
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Table 1
DAI of colitis in mice from four groups.
Group (n=10) 1st day 9th  day 12th day 14th day
Control 0 0 b 0 b 0 b
DSS 0 6.53依1.49 a 4.13依1.52 a 3.46依1.49 a
DSS plus SASP 0 6.14依1.23 a 2.98依1.16 a,b, 1.14依1.12 a,b,
DSS plus  pect ic 
polysaccharides
0 a 6.22依1.26 a 3.02依1.27a,b 1.25依1.27a, b
Female BALB/c mouse were given 4% DSS, in their drinking water 
during the first 7 days, excepted control mouse. Subsequently, DSS was 
removed, and the animals received normal saline (control group and 
DSS group) or SASP (UC plus SASP group) or pectic polysaccharides (UC 
plus pectic polysaccharides group) orally each day. The DAI value was 
calculated as described under experimental. 
  aP <0.05 vs. control group; b P <0.05 vs. DSS group.
     C: DSS plus SASP  group                         D: DSS plus pectic polysaccharides group
A: control group                                                 B:   DSS group
Table 2
Effect of pectic polysaccharide on clinical indices and histological 
injury scores.
Group n Histological scores
control 10 0 b
DSS 10 16.78+2.48 a
DSS plus SASP 10   5.78+1.96 a,,b
DSS plus pectic polysaccharides 10   6.42+2.08 a, b
a P<0.05 vs. control group; b P<0.05 vs. DSS group.
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Figure 1. Hematoxylin and eosin staining (magni cation X 100) of
colonic mucosal tissue section from mice control (A, normal control,
n=lO), DSS (B, DSS + saline, n=lO), DSS plus SASP (C, DSS +
SASP, n=lO), DSS plus pectic polysaccharides (D, DSS + pectic
polysaccharides, n=10).
Evaluation of leukocyte recruitment was assessed by
the measurement of myeloperoxidase activity. As shown
in Table 2, MPO activity levels were low in the colonic
tissues of normal control mice and markedly increased in
mice with DSS-induced colitis. However, MPO activity was
significantly lower in mice with pectic polysaccharides and
SASPthan those with DSS-induced colitis (P<0.05).
3.4. Effects ofpectic polysaccharides on myeloperoxidase
activity
Ob
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. ± . a.b,
2 ± . ~ b
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cell infiltration and extensive destruction of mucosal layer
were observed in the mucosa' of DC group animals. DC
plus pectic polysaccharides group revealed attenuation
in inflammation, characterized by suppression of erosion,
ulceration, reduction in inflammatory cellular infiltrate, and
protection against epithelium damage, although oedema was
still existed (fable 2).
l
r .
When mice were treated with 4% DSS, the levels of NF- Ie B
p65 were significantly increased, otherwise I Ie B- a protein
was decreased in colonic tissue (Figure 2). In the case of
NF- Ie B p65, treatments with Pectic polysaccharides and
SASP resulted in a decrease of expression. However, I Ie B-
a protein was increased in DC plus pectic polysaccharides
group and DC plus SASP group, when compared with DC
group in murine colon tissues by Western blot (P<0.05,Table
3).
3.3. Effects of pectic polysaccharides on TNF- a and
interleukin-6 serum levels
IL-17 and TNF- a are considered important inflammatory
mediators that playa key role in the pathogenesis of DC. In
normal stimulation, colon cells release of pro-inflammatory
cytokines, including IL-17 and TNF- a is protective
in fighting off pathogens like bacteria, for example. To
determine the effect of Pectic polysaccharides on major
inflammatory cytokines in the colon, we determined the
levels of IL-17and TNF- a (Figure 3). After 7 d of DSS
administration, the levels of IL-17and TNF- a increased
significantly. Pectic polysaccharides and SASP group;
Likewise, IL-17 and TNF- a were down regulated in
colon culture supernatants of DC patients by cultured with
pectic polysaccharides and SASP group(Figure 4B).These
results indicated that pectic polysaccharides have anti-
inflammatory effects in the DSS-induced colitis mouse
Compared with that of normal controls, colon of DSS-
treated mice showed complete destruction of epithelial
architecture with loss of crypts and epithelial integrity,
submucosal edema, and intense inflammatory cellular
in all layers. Pectic polysaccharides and SASP treatment
attenuated morphological damage but showed mild cellular
infiltrate.
I .
b
a
a"b
a,b
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NF-kB P65
I毷B-毩
GADPH
A                           B                             C                           D
Table 3
Western blot results display protein expression of NF-kB P65/I毷B毩 
in the colonic tissues.
Group n NF-毷 B P65 I毷B-毩
control 10  24.47依3.83b 43.18依2.13b
DSS 10  54.62依11.45a 18.16依4.19a
DSS plus SASP 10  29.64依7.64a,b 37.71依3.88a,b
DSS plus pectic polysaccharides 10  31.41依8.43a,b 39.28依3.75a,b
a P<0.05 vs. control group; b P<0.05 vs. DSS group.
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4. Discussion
K K - a
Figure 3. Pectic polysaccharides reduced proinflammatory cytokines
production in colitis.
After 14 d, mice were sacrificed and colon tissues were used for
evaluating the levels ofIL-17 andTNF- a byELISA analysis.
has become an alternative therapy in addition to the
conventional therapies that are used to treat UC.
In the present study, we demonstrated that pectic
polysaccharides extracted from Rauvolfia verticillata (Lour.)
Baill.var.hainanensis Tsiang has an anti-inflammatory
effect on colonic injury provoked by oral supplementation
with DSS in mice. DSS-induced colitis is a well-established
model that is phenotypically similar to UC in humans[15J.
Oral administration of DSS for several days, leads to colonic
epithelial lesions and acute inflammation characterized
by the presence of neutrophils and macrophages within
damaged segments. The reason for the deleterious effects
of DSS is not well understood, however, epithelial cell
permeability and macrophage activation have been proposed
as potential mechanisms[16J. We administered pectic
polysaccharides to evaluate the role of treatment with this
product. The results presented herein clearly indicated that
pectic polysaccharides efficiently relieved the symptoms of
DSS-induced colitis in mice. In this study, we showed that
pectic polysaccharides decreased DAI scores in mice with
DSS-induced colitis, mitigated colitis-induced histological
damage by suppression of erosion, ulceration, reduction in
inflammatory cellular infiltrate.
To further characterize the nature of the inhibitory effect
of pectic polysaccharides on pro-inflammatory proteins
production, the NF- f( B signal transduction pathway was
examined. NF- f( B is the major transcription factor which
mediates inflammatory signaling[17.18J. A large number of
studies showed that NF- f( B played a broad regulatory role
in ulcerative colitis, promoted expression of various pro-
inflammatory cytokines including IL-17 and TNF- a . NF-
f( B exists mainly as a heterodimer composed of subunits
of the ReI family, p50 and p65. In resting stage, NF- f( B
normally localizes to the cytoplasm, where it is bound by I
f( B- a protein. During inflammatory stimulus, I f( B- a
is phosphorylated by I f( B kinase, subsequently degraded
by proteasome, then NF- f( B gets released and translocates
into the nucleus, where it triggers the transcription of
multiple genes involved in inflammatory cascade[19J. The
results of this study suggested that pectic polysaccharides
increased the production of I f( B- a protein and decreased
the expression of NF- f( B p65.These indicated that pectic
polysaccharides exhibited anti-inflammatory effects on
ulcerative colitis which might be due to the inhibition of
NF- f( B signal transduction pathways[20J.
In pathological conditions, including oxidative stress,
toxicity, colon cells can be over stimulated and produce
excess pro-inflammatory cytokines which result in
inflammatory bowel disease like UC. IL-17 and TNF- a have
been described as a key molecule in UC pathogenesis[21J.
These cytokine, recruits leukocytes to inflammatory sites,
stimulates monocytes and vascular endothelial cells to
express cytokines, induces the cascade effects for other
cytokines, and finally results in inflammatory lesions
in tissues. Our data showed that pectic polysaccharides
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UCis a chronic, relapsing disease that causes inflammation
and ulcerations of the colonic mucosa with a variable
extent and severity. The etiology of UC remains essentially
unknown but the results from many studies in humans and
animal models suggest that it is related to an abnormal
immune response in the gastrointestinal tract, possibly
associated with genetic and environmental - mainly
microbial - factors[12J. Aminosalicylates, glucocorticoids
and immunosuppressive drugs have been mainly used for
the treatment and maintenance of remission of UC, but the
side effects or toxicity of these drugs represents a major
clinical problem[13,14J. For these reasons, natural medicine
Figure 2. Western blot results display protein expression of NF-kB
P651I K B a in thecolonic tissues.
A: control group;B: DSS group;C: DSS plus pectic polysaccharides
group; 0: DSS plusSASP group.
The expression of NF- K B P65 was increased in DSS-treated mice,
which was markedly inhibited in pectic polysaccharides and SASP
treated mice. In contrast, the expression of I K B a protein was
decreased in DSS-treated mice compared with normal control group,
but increasedsignificantly after treatment of petie polysaccharides
andSASP. P<O.05 versus DSS group andnormal control group, each
group, n=lO.
t /1 K a
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reduced protein expression of IL-17 and TNF- a in mice
with DSS-induced colitis. These results suggested that
pectics exerted anti-inflammatory effects in DC. The results
consisted with previous studies.
The reduction of inflammatory mediators IL-17 and TNF-
a expression induced by pectic polysaccharides can be
correlated with its antioxidant properties. The effects of
antioxidant agents have been ascribed by some authors to
inhibition of activation of the NF- I<: B, which is activated
by ROS with the subsequent induction and expression of
various cytokines (such as IL-17) that are involved in the
induction and development of DC.
A previous study has demonstrated the ability of pectic
polysaccharides to modulate macrophage function through
inhibition of chemotaxis and phagocytosis. Macrophages are
one of the main sources of cytokines tie. IL-17 and TNF-
a ), therefore, a possible modulation of macrophage activity
by pectic polysaccharides could influence the decrease
in cytokine production. This result suggests an important
role for pectic polysaccharides as a modulator of the
immune system and should be taken into account for future
investigations.
In conclusion, the results showed that pectic
polysaccharides extracted from Rauvolfia verticillata
(Lour.) Baill.var.hainanensis Tsiang is able to prevent body
weight loss and colon shortness, as well as increased the
production of I I<: B- a protein, decreased the expression
of NF- I<: B p65, inhibited the level of IL-17 and TNF- a
. Rauvolfia verticillata (l.our.) Baill. var. hainanensis Tsiang
might ameliorate ulcerative colitis and exhibit its anti-
inflammatory effects via increased expression of I I<: B- a
proteins and suppressing NF- I<: B translocation.
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